| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO | Chief Accounting Officer
2 companies
Wilson Marc is a CFO at Crinetics Pharmaceuticals, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $5.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 26, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | CFO | Sale+OE | 25,000 | $51.11 | $1,277,750.00 | -18.4% | +6.6% | -9.2% | |
| Jul 25, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | CFO | Sale+OE | 19,056 | $53.88 | $1,026,737.28 | -14.6% | +9.5% | -41.9% | |
| Jul 15, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | CFO | Sale+OE | 25,000 | $55.00 | $1,375,000.00 | -18.4% | -1.9% | -41.2% | |
| Jun 28, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | CFO | Sale+OE | 32,129 | $43.61 | $1,401,145.69 | -22.4% | +12.9% | -33.1% | |
| Mar 19, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | CFO | Sell | 6,942 | $42.91 | $297,881.22 | -5.9% | -1.0% | -23.3% | |
| Jan 2, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | CFO | Sale+OE | 10,000 | $35.47 | $354,700.00 | -9.4% | +31.5% | +45.7% | |
| Nov 1, 2023 | CRNX Crinetics Pharmaceuticals, Inc. | CFO | Sale+OE | 10,000 | $28.75 | $287,500.00 | -9.5% | +25.3% | +89.4% | |
| Jun 20, 2023 | CRNX Crinetics Pharmaceuticals, Inc. | CFO | Sale+OE | 30,922 | $19.97 | $617,403.12 | -14.0% | +43.3% | +121.3% |